JP2017519763A5 - - Google Patents

Download PDF

Info

Publication number
JP2017519763A5
JP2017519763A5 JP2016573565A JP2016573565A JP2017519763A5 JP 2017519763 A5 JP2017519763 A5 JP 2017519763A5 JP 2016573565 A JP2016573565 A JP 2016573565A JP 2016573565 A JP2016573565 A JP 2016573565A JP 2017519763 A5 JP2017519763 A5 JP 2017519763A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
neprosin
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016573565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017519763A (ja
JP6829077B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2015/000389 external-priority patent/WO2015192211A1/en
Publication of JP2017519763A publication Critical patent/JP2017519763A/ja
Publication of JP2017519763A5 publication Critical patent/JP2017519763A5/ja
Priority to JP2021007953A priority Critical patent/JP7369893B2/ja
Application granted granted Critical
Publication of JP6829077B2 publication Critical patent/JP6829077B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016573565A 2014-06-16 2015-06-16 グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法 Active JP6829077B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021007953A JP7369893B2 (ja) 2014-06-16 2021-01-21 グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462012865P 2014-06-16 2014-06-16
US62/012,865 2014-06-16
US201562118396P 2015-02-19 2015-02-19
US62/118,396 2015-02-19
PCT/CA2015/000389 WO2015192211A1 (en) 2014-06-16 2015-06-16 Compositions and methods for treating gluten intolerance and disorders arising therefrom

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021007953A Division JP7369893B2 (ja) 2014-06-16 2021-01-21 グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2017519763A JP2017519763A (ja) 2017-07-20
JP2017519763A5 true JP2017519763A5 (enExample) 2018-07-26
JP6829077B2 JP6829077B2 (ja) 2021-02-10

Family

ID=54934596

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016573565A Active JP6829077B2 (ja) 2014-06-16 2015-06-16 グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法
JP2021007953A Active JP7369893B2 (ja) 2014-06-16 2021-01-21 グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021007953A Active JP7369893B2 (ja) 2014-06-16 2021-01-21 グルテン不耐症及びそれから生じる障害を治療するための組成物及び方法

Country Status (8)

Country Link
US (3) US20160022785A1 (enExample)
EP (2) EP3943104A1 (enExample)
JP (2) JP6829077B2 (enExample)
CN (2) CN113827708A (enExample)
DK (1) DK3220946T3 (enExample)
ES (1) ES2883347T3 (enExample)
SI (1) SI3220946T1 (enExample)
WO (1) WO2015192211A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160022785A1 (en) 2014-06-16 2016-01-28 Nepetx, Llc Compositions and methods for treating gluten intolerance and disorders arising therefrom
JP2019504011A (ja) 2015-12-16 2019-02-14 ネプエトゥクス，エルエルシー グルテン不耐症およびそれにより発生する障害を治療するための組成物および方法
CN108504615B (zh) * 2018-03-30 2020-12-29 江南大学 一种产酸性蛋白酶的重组菌及其应用
EP4522200A2 (en) * 2022-05-10 2025-03-19 Codexis, Inc. Recombinant neprosin polypeptides and methods of expression
CN115336666A (zh) * 2022-07-05 2022-11-15 熊子奕 猪笼草捕虫囊蛋白酶降低乳清蛋白致敏性的应用及方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK81193D0 (da) 1993-07-06 1993-07-06 Novo Nordisk As Enzym
JP3767831B2 (ja) 1995-06-14 2006-04-19 木村 健 ヘリコバクター・ピロリ除菌用組成物
JPH1149697A (ja) 1997-08-01 1999-02-23 Nisshin Flour Milling Co Ltd ストレス抑制剤及びストレス抑制用食品
DE19980245D2 (de) 1998-02-23 2001-05-10 Keller Helmut Verwendung eines Preßsaftes, Verdauungssaftes oder Extraktes von fleischfressenden Pflanzen zur Hemmung von Proteinkinasen
FI980410A0 (fi) 1998-02-23 1998-02-23 Tapio Raivio Termoset
US7169175B2 (en) 2000-05-22 2007-01-30 Orbusneich Medical, Inc. Self-expanding stent
ATE505201T1 (de) 2002-02-14 2011-04-15 Univ Leland Stanford Junior Enzymbehandlung von nahrungsmitteln für zöliakie- sprue
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
JP4415244B2 (ja) 2003-02-21 2010-02-17 グリコ栄養食品株式会社 小麦蛋白質にプロテアーゼを限定的に作用させて得られる食品素材
US7122035B2 (en) 2003-11-13 2006-10-17 Jerome Canady Bipolar surgical forceps with argon plasma coagulation capability
CN100384442C (zh) * 2004-01-13 2008-04-30 吴琼汉 一种中草药制剂及其制备方法和应用
US7628985B2 (en) 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US20060095096A1 (en) 2004-09-09 2006-05-04 Debenedictis Leonard C Interchangeable tips for medical laser treatments and methods for using same
EP1856291A4 (en) 2005-03-04 2009-04-01 Verenium Corp NUCLEIC ACIDS AND PROTEINS, AND METHODS OF MAKING AND USING SAME
EP1949093A2 (en) 2005-10-11 2008-07-30 Alvine Pharmaceuticals, Inc. Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides
AU2007299219A1 (en) 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
US20080115411A1 (en) 2006-11-16 2008-05-22 Ramsey Philip W Weed control system
US7645977B2 (en) 2006-11-17 2010-01-12 New Visual Media Group, L.L.C. Low cost dynamic insulated glazing unit
CN101627098B (zh) 2006-12-04 2013-04-24 三菱瓦斯化学株式会社 含有甲醛系聚合物的树脂材料的粘接方法以及结构体
WO2008115428A2 (en) 2007-03-16 2008-09-25 The Board Of Trustees Of The Leland Stanford Junior University A scaleable manufacturing process for cysteine endoprotease b, isoform 2
EP2136833B1 (en) 2007-03-16 2019-05-01 The Board of Trustees of the Leland Stanford Junior University Combination enzyme therapy for digestion of dietary gluten
EP2229404A4 (en) 2007-12-10 2011-03-09 Univ Leland Stanford Junior ENZYMATIC POLYTHERAPY FOR GASTRIC DIGESTION OF FOOD GLUTEN IN PATIENTS WITH CELIAC DISEASE
EP2100900A1 (en) 2008-03-07 2009-09-16 Universitätsspital Basel Bombesin analog peptide antagonist conjugates
AU2009283157B2 (en) 2008-08-21 2015-02-26 Alvine Pharmaceuticals, Inc. Formulation for oral administration of proteins
EP2344183B1 (en) 2008-10-10 2015-02-25 Alvine Pharmaceuticals, Inc. Dosage forms that facilitate rapid activation of zymogen
CN101732504A (zh) * 2010-01-06 2010-06-16 宋晓翠 猪笼草和艾蒿、香蒲草制成的妇科药物及其制备方法
EP2531521B1 (en) 2010-02-02 2017-09-06 Amano Enzyme USA., Ltd. Use of proteases for gluten intolerance
EP2555792A4 (en) 2010-03-30 2013-11-06 Alvine Pharmaceuticals Inc PROTEASES DEGRADING GLUTEN
US9598684B2 (en) 2010-07-07 2017-03-21 Trustees Of Boston University Rothia species gluten-degrading enzymes and uses thereof
US9023345B2 (en) 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
WO2012145369A1 (en) * 2011-04-22 2012-10-26 Faerstein Paul Joseph Compositions and methods for nutritional supplementation
US9005610B2 (en) 2012-11-21 2015-04-14 Nepetx, Llc Treatment of gluten intolerance and related conditions
US8837173B2 (en) 2013-01-02 2014-09-16 Chicony Power Technology Co., Ltd DC to DC power converting device
WO2014116871A1 (en) 2013-01-23 2014-07-31 Alvine Pharmaceuticals, Inc. Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance
US20160022785A1 (en) 2014-06-16 2016-01-28 Nepetx, Llc Compositions and methods for treating gluten intolerance and disorders arising therefrom
JP2019504011A (ja) 2015-12-16 2019-02-14 ネプエトゥクス，エルエルシー グルテン不耐症およびそれにより発生する障害を治療するための組成物および方法

Similar Documents

Publication Publication Date Title
Reyes‐Díaz et al. Immunomodulation by hydrolysates and peptides derived from milk proteins
JP2017519763A5 (enExample)
JP2015517489A5 (enExample)
BRPI1013877A2 (pt) Sequências de aminoácidos melhoradas contra il-6r e polipeptídeos que compreendem os mesmos para o tratamento de doenças e distúrbios relacionados com il-6r
JP2019533722A5 (enExample)
JP2018511327A5 (enExample)
JP2015510393A5 (enExample)
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
Edwards et al. Perinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: A case for cationic arginine-rich peptides (CARPs)
JP2014530010A5 (enExample)
TWI797116B (zh) 用於治療上皮細胞屏障功能病症的蛋白質
JP6158712B2 (ja) 新規合成ペプチド及びそれらの使用
JP2006506942A5 (enExample)
JP2011528897A5 (enExample)
YF Chen et al. Potential clinical applications of multi-functional milk proteins and peptides in cancer management
MX2014004953A (es) Ligadores basados en tirosina para la conexion desprendible de peptidos.
RU2016108808A (ru) Терапевтическое применение vegf-c и ccbe1
WO2017137920A3 (en) Use of bacterial strains belonging to the species lactobacillus kefiri in paediatrics to generate and/or maintain a state of homeostasis
Litvinenko et al. Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy
WO2020077010A1 (en) Lactococcus lactis expression system for delivering proteins efficacious for the treatment of epithelial barrier function disorders
HRP20161147T1 (hr) Farmaceutski sastav i postupak njegove proizvodnje
WO2016090022A8 (en) Polypeptides comprising a modified bacteriophage g3p amino acid sequence lacking a glycosylation signal